1. Dermatological side‐effects in hepatitis C infected patients under a triple regimen associating pegylated interferon, ribavirin and telaprevir. (3rd September 2014) Authors: Bernardeschi, C.; Valeyrie‐Allanore, L.; Ortonne, N.; Gressier, L.; Wallet‐Faber, N.; Bernard, P.‐H.; Hezode, C.; Duclos‐Vallée, J.‐C.; Samuel, D.; Mallet, V.; Pol, S.; Milpied, B.; Dupin, N. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 1(2016:Jan.) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0235 Interferon-free antivirals for hepatitis c virus-associated cryoglobulinemia vasculitis: a long-term follow-up study. (12th June 2018) Authors: Cacoub, P.; Si ahmed, S.N.; ferfar, Y.; Pol, S.; Thabut, D.; Hezode, C.; Alric, L.; Comarmond, C.; Ragab, G.; Quatuccio, L.; Hegazy, M.; Poynard, T.; Resche Rigon, M.; Saadoun, D. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗